Advantages and clinical applications of natural killer cells in cancer immunotherapy
about
Immune targeting of cancer stem cells in gastrointestinal oncologyIn vivo monitoring of natural killer cell trafficking during tumor immunotherapyEmerging role of Natural killer cells in oncolytic virotherapyLow Dose Focused Ultrasound Induces Enhanced Tumor Accumulation of Natural Killer Cells.Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids.High level of Tregs is a positive prognostic marker in patients with HPV-positive oral and oropharyngeal squamous cell carcinomas.Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours.Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspectiveRecognition of tumors by the innate immune system and natural killer cells.Hydroferrate fluid, MRN-100, provides protection against chemical-induced gastric and esophageal cancer in Wistar rats.Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cellsA High-Throughput Assay for Screening of Natural Products that Enhanced Tumoricidal Activity of NK CellsNK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell PhenotypeNK Cell-Dependent Growth Inhibition of Lewis Lung Cancer by Yu-Ping-Feng, an Ancient Chinese Herbal FormulaDefining Metastatic Cell LatencyIon channels and anti-cancer immunity.Role of NK cells in immunotherapy and virotherapy of solid tumors.Natural killer cell receptors: alterations and therapeutic targeting in malignancies.NK cell-based cancer immunotherapy: from basic biology to clinical application.Enhancement of NK cells proliferation and function by Shikonin.Potential Cancer Prevention and Treatment by Silencing the Killer Cell Immunoglobulin-like Receptor Gene in Natural Killer Cells Derived from Induced Pluripotent Stem Cells.Myeloma cells resistance to NK cell lysis mainly involves an HLA class I-dependent mechanism.Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy.NK cell therapy for end-stage cancerous patient: A case study.Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers.Complement Receptor 3 Has Negative Impact on Tumor Surveillance through Suppression of Natural Killer Cell Function.Immunotherapeutic interventions of Triple Negative Breast Cancer.
P2860
Q26749015-CF6EC051-A174-40FF-A83A-F6D046BDE114Q27011245-7384FAAE-302A-44D8-8B63-961A077868FAQ27025330-77D14FE1-7A65-45FC-B955-F703396E7E46Q30398870-A6FF0CED-5D1C-4324-86C1-3B7B122E980CQ30648415-5103CDE9-AD9A-4D31-8B39-CBB8B5601B42Q33597525-3A0441CD-CB3B-48A7-A438-4E39D127538FQ33861833-3F07BAB4-464C-4621-92C2-283E1DC996BAQ34180695-86FA7DAD-E80A-4024-9BEB-407B59A1CF2EQ34496462-FD7B5621-7DCC-4C8D-B5C4-D84D4EF18B47Q35069202-711DDA7F-E170-4DA5-8784-DD6BC0FC805FQ36060236-0508855D-CBEA-449B-82CE-C17C1DFDB2D9Q36222619-D100022A-428A-421D-9454-78CDB839FCAEQ36660550-BF710A42-2338-4C3D-895D-DEC5AA16762FQ36681210-AB8DFC4A-22D6-4BD7-A413-D9CAAA62E5B0Q37258355-0C69BAF9-07E6-41F1-8F2D-492F74E42492Q37566472-EA2EA3B2-1D69-47EF-B2B4-39AE9BC49AEEQ38575116-1D39B81E-4A63-4227-BFFC-20C024674C3EQ38587627-0860A787-6763-4D7D-A676-7462D5BDF304Q38640489-7B9BED31-C8D3-42C9-B72B-79FC58C631D1Q38711887-AD3BC908-3395-4B1D-961C-010D59609B3FQ38790470-DD078EA0-1A20-4AC5-863E-A48FCA76918AQ38992850-26658E77-74CF-4F0E-9552-F7AF23259C43Q39037708-708FFF11-F4B3-4491-8E69-4E5CE42EAD85Q39394076-BFF587C7-5FCC-4EFA-8F02-BDB7913BC0AFQ46366459-A9D3E812-11C9-4885-AE15-F7C023962E82Q47120622-332FC240-00B6-4922-BEB7-FCE6882F719CQ55257180-3298424B-075A-4EDA-989C-16F89F61EFD4
P2860
Advantages and clinical applications of natural killer cells in cancer immunotherapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Advantages and clinical applications of natural killer cells in cancer immunotherapy
@ast
Advantages and clinical applications of natural killer cells in cancer immunotherapy
@en
Advantages and clinical applications of natural killer cells in cancer immunotherapy
@nl
type
label
Advantages and clinical applications of natural killer cells in cancer immunotherapy
@ast
Advantages and clinical applications of natural killer cells in cancer immunotherapy
@en
Advantages and clinical applications of natural killer cells in cancer immunotherapy
@nl
prefLabel
Advantages and clinical applications of natural killer cells in cancer immunotherapy
@ast
Advantages and clinical applications of natural killer cells in cancer immunotherapy
@en
Advantages and clinical applications of natural killer cells in cancer immunotherapy
@nl
P2860
P1476
Advantages and clinical applications of natural killer cells in cancer immunotherapy
@en
P2093
William J. Murphy
P2860
P2888
P356
10.1007/S00262-013-1469-8
P407
P577
2014-01-01T00:00:00Z
P6179
1007285873